Results 141 to 150 of about 12,300 (184)

Differential methylation of <i>SNCA</i> and <i>MAPT</i> genes associated with Parkinson's disease in Mexican Mestizos. [PDF]

open access: yesFront Aging Neurosci
Miranda-Morales EG   +11 more
europepmc   +1 more source

Molecular mechanisms of α-syn abnormal phase separation in cognitive impairment induced by chronic intermittent hypoxia and the neuroprotective effects of Danshensu methyl ester. [PDF]

open access: yesMol Med
Li J   +17 more
europepmc   +1 more source

Gabapentinoids promote striatal dopamine release and rescue multiple deficits of a mouse model of early Parkinson’s

open access: yes
Brimblecombe KR   +10 more
europepmc   +1 more source

A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease [PDF]

open access: yesMovement Disorders, 2021
ABSTRACTBackgroundThe SNCA gene encoding α‐synuclein (αSyn) is the first gene identified to cause autosomal‐dominant Parkinsonʼs disease (PD).ObjectiveWe report the identification of a novel heterozygous A30G mutation of the SNCA gene in familial PD and describe clinical features of affected patients, genetic findings, and functional consequences ...
Hui Liu, Christos Koros, Claudia Schulte
exaly   +6 more sources

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation [PDF]

open access: yesMolecular Neurodegeneration, 2015
We and others have described the neurodegenerative disorder caused by G51D SNCA mutation which shares characteristics of Parkinson's disease (PD) and multiple system atrophy (MSA). The objective of this investigation was to extend the description of the clinical and neuropathological hallmarks of G51D mutant SNCA-associated disease by the study of two ...
Aoife P Kiely   +2 more
exaly   +9 more sources

Home - About - Disclaimer - Privacy